SBH1 Antibody

What is SBH1 and what are its primary functions?

SBH1 (Sec61 beta homolog 1) is a highly conserved subunit of the endoplasmic reticulum (ER) protein translocation channel. Despite being nonessential, SBH1 plays a significant role in promoting ER translocation of proteins with suboptimal targeting sequences . The SBH1 protein contains an intrinsically unstructured cytosolic domain that makes transient contact with ER-targeting sequences in the cytosolic channel vestibule . Research indicates that approximately 12% of secretory proteins depend on SBH1 for effective translocation into the ER .

In a separate context, SBH-1 refers to a Reed-Sternberg-like cell line established from the pleural effusion of a previously untreated patient, which exhibits morphologic, immunophenotypic, and karyotypic features consistent with Reed-Sternberg (RS) and Hodgkin (H) cells .

How can I detect SBH1 expression in my experimental system?

Detection of SBH1 expression can be achieved through several methodological approaches:

• Western Blotting: Using validated SBH1 antibodies at appropriate dilutions (typically 1/500 as seen with some phospho-specific antibodies) against protein extracts from your experimental system . Expected band size for full-length SBH1/Sec61β protein is around 10 kDa, though this varies depending on post-translational modifications.

• Immunofluorescence: For cellular localization studies, using fluorophore-conjugated secondary antibodies against primary SBH1 antibodies. This allows visualization of SBH1's characteristic ER membrane localization pattern.

• RT-PCR: Measuring SBH1 mRNA expression levels using validated primers targeting SBH1-specific sequences.

• RNA-Seq: For comprehensive transcriptomic analysis, which can be particularly useful when studying SBH1 expression changes under different experimental conditions.

What are the key characteristics of SBH1-dependent proteins?

SBH1-dependent proteins share several distinguishing features:

• Suboptimal ER-targeting sequences: These proteins typically have signal sequences with less pronounced hydrophobicity compared to SBH1-independent proteins .

• Lack of charge bias or inverse charge bias: Many SBH1-dependent proteins have targeting sequences that either lack the typical positive-to-negative amino acid charge distribution or display an inverse pattern, which reduces their insertion efficiency into the Sec61 channel .

• Critical ER function: Some SBH1-dependent proteins include enzymes whose precise concentration in the ER lumen is critical for maintaining ER proteostasis .

The table below summarizes the key differences between SBH1-dependent and SBH1-independent proteins:

What are the recommended protocols for studying SBH1's role in protein translocation?

To effectively study SBH1's role in protein translocation, researchers should consider these methodological approaches:

• Genetic deletion studies: Comparing translocation efficiency in wild-type versus SBH1-deletion strains (sbh1Δ) or double deletion strains (sbh1Δsbh2Δ) for proteins of interest .

• Microscopic screening: Implementing high-content screening using GFP-tagged secretory protein libraries to identify SBH1-dependent substrates. This approach has successfully identified approximately 12% of secretory proteins as SBH1-dependent .

• Site-directed mutagenesis: Creating specific mutations in the SBH1 gene, particularly at N-terminal phosphorylation sites, to assess their impact on protein translocation efficiency. For example, mutating proline-flanked phosphorylation sites to alanine has been shown to phenocopy temperature-sensitivity in yeast strains lacking SBH1 and its ortholog SBH2 .

• In vitro translocation assays: Using microsomal membranes prepared from wild-type or sbh1Δ cells to assess the translocation efficiency of radioactively labeled proteins synthesized in cell-free translation systems.

How can I assess the specificity of an SBH1 antibody for my research?

Assessing antibody specificity is critical for reliable research outcomes. For SBH1 antibodies, consider these methodological approaches:

• Validation using knockout/knockdown controls: Test the antibody in samples where SBH1 has been genetically deleted or knocked down. A specific antibody should show significantly reduced or absent signal in these samples.

• Cross-reactivity testing: Evaluate potential cross-reactivity with closely related proteins, particularly SBH2, which shares significant homology with SBH1.

• Epitope mapping: Determine the specific region of SBH1 that the antibody recognizes, which is particularly important when studying truncated forms or specific post-translational modifications.

• Multiple detection methods: Confirm findings using alternative detection methods such as mass spectrometry or RNA analysis to corroborate antibody-based results.

• Phospho-specific validation: For phospho-specific SBH1 antibodies, treat samples with phosphatases to confirm that the signal disappears when the phosphorylation is removed .

How does phosphorylation affect SBH1 function in protein translocation?

Phosphorylation plays a critical regulatory role in SBH1 function:

• N-terminal phosphorylation sites: The SBH1 cytosolic domain contains multiple phosphorylation sites, with two N-terminal, proline-flanked sites being particularly important. Mutating these sites to alanine has been shown to phenocopy temperature-sensitivity in strains lacking both SBH1 and SBH2 .

• Phosphorylation-dependent substrate selection: A subset of SBH1-dependent proteins (approximately 2% of screened proteins) specifically requires N-terminal phosphorylation of SBH1 for efficient translocation into the ER .

• Role of proline isomerase: The activity of Ess1 (PIN1 in mammals), a phospho-S/T-specific proline isomerase, is required for the translocation of phosphorylation-dependent SBH1 substrates. This suggests that a conformational change induced by phosphorylation is crucial for SBH1's function with certain substrates .

• Regulatory mechanism: Evidence suggests that SBH1 activity can be regulated by conformational changes induced by N-terminal phosphorylation, providing a potential mechanism for fine-tuning ER protein import based on cellular conditions .

What are the experimental challenges in differentiating between SBH1 and SBH2 functions?

Differentiating between SBH1 and SBH2 functions presents several methodological challenges:

• Functional redundancy: SBH1 and SBH2 exhibit partial functional redundancy, making it difficult to isolate their individual contributions. Studies have reported variable effects of SBH1 and SBH2 deletion on protein translocation of different substrates .

• Context-dependent effects: The relative importance of SBH1 versus SBH2 may vary depending on experimental conditions, cell types, or specific substrate proteins.

• Experimental design considerations:

  • Single versus double knockout/knockdown approaches

  • Substrate-specific assays to detect subtle differences

  • Quantitative rather than qualitative readouts

  • Stress conditions that may reveal differential functions

• Technical approach: Implementing complementation assays where either SBH1 or SBH2 is reintroduced into double-deletion strains can help identify specific functions. Additionally, creating chimeric proteins with domains swapped between SBH1 and SBH2 can help map function-specific regions.

How can advanced structural biology techniques be applied to study SBH1-antibody interactions?

Contemporary structural biology offers powerful approaches to investigate SBH1-antibody interactions:

• Cryo-electron microscopy (Cryo-EM): Particularly valuable for studying SBH1 in its native context as part of the Sec61 complex. Recent advances in Cryo-EM have contributed to the significant increase (136% with respect to the five years preceding 2021) in experimentally determined antibody-antigen structures .

• X-ray crystallography: Can provide high-resolution structures of antibody-SBH1 complexes, though crystallizing membrane proteins like SBH1 presents technical challenges.

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Useful for mapping conformational changes in SBH1 upon antibody binding, especially important for understanding how antibodies might affect SBH1's function.

• Surface plasmon resonance (SPR) and bio-layer interferometry (BLI): For quantitative analysis of binding kinetics between SBH1 and specific antibodies.

• Computational approaches: Leveraging the growing database of antibody-antigen structures to predict and design antibodies with custom specificity profiles for SBH1 . Recent advances enable the computational design of antibodies with:

  • Specific high affinity for particular epitopes of SBH1

  • Cross-specificity for multiple related targets (e.g., both SBH1 and SBH2)

  • Customized binding to specific conformational states of SBH1

How should I interpret conflicting results between different SBH1 antibodies?

When faced with conflicting results between different SBH1 antibodies, consider these methodological approaches:

• Epitope mapping: Determine whether the antibodies recognize different epitopes on SBH1, which could explain divergent results if:

  • The epitopes are differentially accessible in various experimental conditions

  • Post-translational modifications mask certain epitopes

  • Protein-protein interactions shield specific regions

• Validation strategy:

  • Use multiple antibodies targeting different regions of SBH1

  • Include proper positive and negative controls (especially knockout/knockdown samples)

  • Complement antibody-based detection with orthogonal methods (mass spectrometry, RNA analysis)

• Experimental conditions: Assess whether differences in sample preparation, fixation methods, or detection systems might contribute to the discrepancies.

• Specificity verification: Perform Western blot analysis to confirm that each antibody detects a band of the expected molecular weight and assess potential cross-reactivity with similar proteins.

What are the key considerations when designing experiments to study SBH1's interactions with reticulon proteins?

Research has shown that SBH1 is found in protein complexes containing not only Rtn1p but also the other reticulon-like proteins Rtn2p and Yop1p . When designing experiments to study these interactions:

• Interaction site mapping: Mutations that affect SBH1's interaction with Sec61p do not necessarily affect its interaction with Rtn1p, suggesting distinct binding interfaces . Use targeted mutagenesis to map the specific regions involved in reticulon binding.

• Functional significance assessment: Design experiments that distinguish between:

  • Physical interactions (co-immunoprecipitation, proximity labeling)

  • Functional interactions (phenotypic analysis of single and double mutants)

  • Direct versus indirect interactions (in vitro binding assays with purified components)

• Membrane topology considerations: Since both SBH1 and reticulons are membrane proteins, consider how membrane curvature and lipid composition might affect their interactions.

• Technical approaches:

  • Bimolecular fluorescence complementation (BiFC) for visualizing interactions in living cells

  • FRET-based assays to detect proximity in native membranes

  • Crosslinking methods optimized for membrane protein interactions

  • Quantitative proteomics to identify interaction partners under different conditions

What methodological approaches are recommended for studying the SBH-1 Reed-Sternberg-like cell line?

The SBH-1 cell line represents a valuable model for studying Reed-Sternberg and Hodgkin cell biology. Recommended methodological approaches include:

• Xenotransplantation models: The SBH-1 cell line can be xenotransplanted into severe combined immunodeficient (SCID) mice, leading to local and disseminated tumor growth that maintains the cytologic, histologic, and immunohistochemical features typical of RS and H cells .

• Cytokine profiling: Analyze expression patterns of cytokines and cytokine receptors, as SBH-1 cells have been shown to express messages for IL-1β, tumor necrosis factor-alpha, transforming growth factor-beta, and various cytokine receptors (IL-2R, IL-4R, IL-6R, and IL-7R) .

• Immunophenotypic characterization: Perform comprehensive immunophenotyping focusing on markers such as CD30, CD15, CD25, CD71, CD45, CD20, CD22, and bcl-2 protein, which are expressed in SBH-1 cells .

• Cytogenetic analysis: Investigate the multiple clonal abnormalities with breakpoints at 14q32, 6q21, and 11q23 that characterize SBH-1 cells .

• Gene rearrangement studies: Examine the rearrangement status of Ig heavy chain genes and both Ig light chain genes, which are rearranged in SBH-1 cells, while the bcl-2 gene remains in germline configuration .

How can I establish and validate an SBH-1 cell-based experimental system?

Establishing and validating an SBH-1 cell-based experimental system requires attention to several methodological aspects:

• Culture conditions optimization:

  • Determine optimal growth media, serum requirements, and supplements

  • Establish growth curves and doubling times

  • Optimize cell density and passage protocols

• Authentication protocols:

  • Perform short tandem repeat (STR) profiling to confirm cell line identity

  • Conduct comprehensive immunophenotyping to verify characteristic marker expression

  • Carry out cytogenetic analysis to confirm the presence of typical chromosomal abnormalities

• Functional validation:

  • Verify cytokine expression and secretion profiles

  • Confirm tumorigenic potential in immunodeficient mice

  • Assess response to standard Hodgkin lymphoma therapeutic agents

• Experimental controls:

  • Include other established Hodgkin lymphoma cell lines as reference controls

  • Consider using primary Reed-Sternberg cells when possible for comparison

  • Implement isogenic control lines when introducing genetic modifications

How does the trans-membrane domain of SBH1 contribute to its function?

Random mutagenesis studies have provided valuable insights into the functional importance of the SBH1 trans-membrane domain:

• Interaction with Sec61p: Mutations identify one side of the SBH1 trans-membrane domain α-helix that is involved in interactions with Sec61p and is important for SBH1 function in protein translocation .

• Differential binding interfaces: Interestingly, mutations that affect the interaction with Sec61p do not affect SBH1's interaction with Rtn1p, suggesting distinct binding interfaces for different partner proteins .

• Structural considerations: The SBH1 trans-membrane domain adopts an α-helical conformation, with specific amino acid residues oriented toward its interaction partners. Hydrophobic and van der Waals interactions likely predominate in these membrane-embedded associations.

• Experimental approaches: To further characterize the role of the trans-membrane domain:

  • Implement scanning mutagenesis covering the entire trans-membrane region

  • Use crosslinking approaches to capture transient interactions

  • Apply computational modeling to predict how specific mutations might alter helical packing and protein-protein interactions

What are the advanced analytical approaches for studying SBH1 post-translational modifications?

Investigating SBH1 post-translational modifications requires sophisticated analytical approaches:

• Mass spectrometry-based strategies:

  • Phosphoproteomics to identify all phosphorylation sites on SBH1

  • Quantitative approaches (SILAC, TMT labeling) to determine changes in phosphorylation under different conditions

  • Top-down proteomics to analyze intact SBH1 molecules with all modifications preserved

• Site-specific antibodies: Using phospho-specific antibodies like those developed for other phosphorylated proteins (e.g., anti-SREBP1 phospho S439) to detect specific phosphorylation states of SBH1.

• Functional consequences assessment:

  • Phosphomimetic mutations (S/T to D/E) to simulate constitutive phosphorylation

  • Phospho-null mutations (S/T to A) to prevent phosphorylation

  • Quantitative translocation assays to measure the impact of these mutations on different substrate proteins

• Kinase/phosphatase identification:

  • Kinase inhibitor screens to identify enzymes responsible for SBH1 phosphorylation

  • Phosphatase inhibitor studies to assess the dynamics of SBH1 phosphorylation

  • Direct in vitro kinase assays with purified components

• Structural studies: Determining how phosphorylation affects SBH1 conformation, particularly focusing on the intrinsically unstructured cytosolic domain and how phosphorylation might induce order in this region.